Jan 25–28, 2027 | Keystone Resort, Keystone, CO, United States
              
              Scientific Organizers:
              
                 
                  Erik J. Sontheimer and Leonela Amoasii
                
                      
            
 
        -
Scientific Organizers: Erik J. Sontheimer and Leonela Amoasii
Erik J. Sontheimer, PhD
University of Massachusetts Medical School
Leonela Amoasii, PhD
Vertex Pharmaceuticals
***Meeting program subject to change.
Available Formats: = In Person = On DemandMerchandise Options
Registration Options
Monday, January 25, 2027
Tuesday, January 26, 2027
Single-AAV base Editing Therapies for Duchenne Muscular Dystrophy
AAV Capsid Engineering for Broad CNS Distribution
Development of Medicines to Treat Prion Diseases: A Personal Journey
AAV-Delivered Epigenome Editors
CRISPR Genome Editing
Next-Generation Genome Editing Platforms
Genome Editing in Hematopoietic Stem Cells
Wednesday, January 27, 2027
Development and Application of Virus-Like Particles for Genome Editing in vivo
mRNA/LNP based Gene Editing
Personalized Therapeutic Genome Editing for Hepatic Inborn Errors of Metabolism
Novel Delivery Strategies for Genetic Medicines
Advancing In Vivo CRISPR CasX-Based Therapies to Target Key Dyslipidemia Drivers
Off-Target Profiling for Base and Prime Editing
Enhancing Prime Editing Platforms for in vivo Applications
Thursday, January 28, 2027
Precise ADAR Base Editors and Prime Editor Enhancers
Transgene Insertion Editing with Engineered Retroelements
Engineering Programmable Transposases
Protein Design and Genome Editor Enhancement
Building Customized Editors via Large Language Model-Based Protein Design
BindCraft, Protein Design, and Control over Genome Editing
Friday, January 29, 2027
Subscribe for Updates